2025-04-14 23:19:03
Latest Post
Orient Cement Ltd Q4 FY2025 PAT up QoQ at Rs. 42.07 crores
Nibe Space Receives IN-SPACe registration for EO Data Dissemination
Elin Electronics Ltd performs Bhoomi Pujan of its manufacturing facility at Bhiwadi
Transrail Lighting Limited wins fresh ₹1,085 Crore Orders 
Electronics Mart India Ltd opens new Bajaj Electronics store at Markapur
Stock Report
Zim Laboratories Ltd Q2 FY2024 consolidated PAT up QoQ at Rs. 4.14 crore
Posted On : 2023-11-02 09:06:46( TIMEZONE : IST )
Zim Laboratories Ltd has reported Consolidated financial results for the period ended September 30, 2023.
Financial Results (Q2 FY2024) - QoQ Comparison
The company has reported total income of Rs. 87.2476 crores during the period ended September 30, 2023 as compared to Rs. 68.5583 crores during the period ended June 30, 2023.
The company has posted net profit / (loss) of Rs. 4.1495 crores for the period ended September 30, 2023 as against net profit / (loss) of Rs. 0.2266 crores for the period ended June 30, 2023.
The company has reported EPS of Rs. 0.85 for the period ended September 30, 2023 as compared to Rs. 0.05 for the period ended June 30, 2023.
| Financials | Q2 FY2024 | Q1 FY2024 | % Change |
| Total Income | ₹ 87.2476 crs | ₹68.5583 crs |  27.26% |
| Net Profit | ₹4.1495 crs | ₹0.2266 crs | 1,731.20% |
| EPS | ₹0.85 | ₹0.05 | 1,600.00% |
Financial Results (Q2 FY2024) - YoY Comparison
The company has reported total income of Rs. 87.2476 crores during the period ended September 30, 2023 as compared to Rs.100.8204 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs.4.1495 crores for the period ended September 30, 2023 as against net profit / (loss) of Rs.5.4497 crores for the period ended September 30, 2022.
The company has reported EPS of Rs.0.85 for the period ended September 30, 2023 as compared to Rs.1.12 for the period ended September 30, 2022.
| Financials | Q2 FY2024 | Q2 FY2023 | % Change |
| Total Income | ₹ 87.2476 crs | ₹100.8204 crs |  -13.46% |
| Net Profit | ₹4.1495 crs | ₹5.4497 crs | -23.86% |
| EPS | ₹0.85 | ₹1.12 | -24.11% |
Financial Results (Half Year Ended FY2024) - YoY Comparison
The company has reported total income of Rs.155.8059 crores during the 6 Months period ended September 30, 2023 as compared to Rs.195.4606 crores during the 6 Months period ended September 30, 2022.
The company has posted net profit / (loss) of Rs.4.3761 crores for the 6 Months period ended September 30, 2023 as against net profit / (loss) of Rs.10.5975 crores for the 6 Months period ended September 30, 2022.
The company has reported EPS of Rs.0.90 for the 6 Months period ended September 30, 2023 as compared to Rs.2.18 for the 6 Months period ended September 30, 2022.
| Financials | Half Year Ended FY2024 | Half Year Ended FY2023 | % Change |
| Total Income | ₹155.8059 crs | ₹195.4606 crs | -20.29% |
| Net Profit | ₹4.3761 crs | ₹10.5975 crs | -58.71% |
| EPS | ₹0.90 | ₹2.18 | -58.72% |
Shares of Zim Laboratories Ltd was last trading in BSE at Rs. 115.60 as compared to the previous close of Rs. 116.85. The total number of shares traded during the day was 10552 in over 283 trades.
The stock hit an intraday high of Rs. 117.95 and intraday low of 115.40. The net turnover during the day was Rs. 1228674.00.
